ALPINE IMMUNE SCIENCES, INC. Increase Decrease In Operating Lease Liability
ALPINE IMMUNE SCIENCES, INC. reported Increase Decrease In Operating Lease Liability of -$259.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2024-05-09
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$259.00K.
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2023-12-31 was -$242.00K.
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2023-09-30 was -$236.00K.
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$230.00K.
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for fiscal 2023 was -$928.00K.
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for fiscal 2022 was -$785.00K.
- ALPINE IMMUNE SCIENCES, INC. increase decrease in operating lease liability for fiscal 2021 was -$844.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$259.00K 10-Q · filed 2024-05-09 | -$501.00K derived: sum of 2 quarters · filed 2024-05-09 | -$737.00K derived: sum of 3 quarters · filed 2024-05-09 | -$967.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | -$242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$478.00K derived: sum of 2 quarters · filed 2024-03-20 | -$708.00K derived: sum of 3 quarters · filed 2024-03-20 | -$928.00K 10-K · filed 2024-03-20 |
| 2023-09-30 | -$236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$466.00K derived: sum of 2 quarters · filed 2023-11-14 | -$686.00K 10-Q · filed 2023-11-14 | -$891.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$450.00K 10-Q · filed 2023-08-14 | -$655.00K derived: sum of 3 quarters · filed 2024-05-09 | -$855.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | -$220.00K 10-Q · filed 2024-05-09 | -$425.00K derived: sum of 2 quarters · filed 2024-05-09 | -$625.00K derived: sum of 3 quarters · filed 2024-05-09 | -$820.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$405.00K derived: sum of 2 quarters · filed 2024-03-20 | -$600.00K derived: sum of 3 quarters · filed 2024-03-20 | -$785.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$395.00K derived: sum of 2 quarters · filed 2023-11-14 | -$580.00K 10-Q · filed 2023-11-14 | -$915.00K derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$380.00K 10-Q · filed 2023-08-14 | -$715.00K derived: sum of 3 quarters · filed 2024-03-20 | -$882.00K derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-03-31 | -$185.00K 10-Q · filed 2023-05-11 | -$520.00K derived: sum of 2 quarters · filed 2024-03-20 | -$687.00K derived: sum of 3 quarters · filed 2024-03-20 | -$851.00K derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-12-31 | -$335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$502.00K derived: sum of 2 quarters · filed 2024-03-20 | -$666.00K derived: sum of 3 quarters · filed 2024-03-20 | -$844.00K 10-K · filed 2024-03-20 |
| 2021-09-30 | -$167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$331.00K derived: sum of 2 quarters · filed 2022-11-14 | -$509.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$342.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$178.00K 10-Q · filed 2022-05-12 |